Riverain nets CE Mark for CAD software November 20, 2015 -- Computer-aided detection (CAD) firm Riverain Technologies has received the CE Mark for marketing its ClearRead CT software in the European Union.
Mirada wins contract for 30 U.K. centers November 10, 2015 -- Medical imaging software developer Mirada Medical announced its XD3 Advanced image review and analysis software is being used by Alliance Medical in partnership with 30 National Health Service (NHS) hospital PET/CT departments nationwide.
CT technique can reduce invasive heart tests October 26, 2015 -- In what is thought to be the largest trial of its kind to date, U.S. and Italian researchers have found that an algorithm measuring blood flow through the coronary arteries based on data from CT images can prevent unnecessary catheterizations.
CAD systems compared: What you should look for October 26, 2015 -- A Dutch study suggests the best computer-aided detection (CAD) system can detect most pulmonary nodules at a low false-positive rate and find additional lesions missed by human readers, but awareness of the varying reliability of different CAD algorithms is crucial.
Mach7, 3D Medical sign merger deal October 26, 2015 -- Image management technology developer Mach7 Technologies and 3D Medical have signed a definitive agreement to merge.
JFR: CT and the amazing case of Louise de Quengo October 22, 2015 -- During the construction of a new congress center in Rennes, France, the site yielded nearly 1,000 graves from between the 14th and 18th centuries. CT was used to study the remains, delegates learned at the French national radiology congress, JFR.
Volpara highlights software in Dutch breast study October 15, 2015 -- Breast imaging software developer Volpara Solutions is highlighting a Dutch breast density study that suggests volumetric density measures could help evaluate breast screening performance, while also identifying high-risk groups.
Median wins 5 new projects October 14, 2015 -- Imaging software developer Median Technologies has signed on to provide image interpretation and management services for five new oncology clinical studies, valued at a total of 4.09 million euros.